Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
Author:
Affiliation:
1. From the Departments of Pathology and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference74 articles.
1. Inflammation and cancer: back to Virchow?
2. Inflammation and cancer
3. PROSTATE PATHOLOGY
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance;The Prostate;2024-01-03
2. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients;The Prostate;2022-07-12
3. Vitamin D and Hypoxia: Points of Interplay in Cancer;Cancers;2022-03-31
4. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer;The Prostate;2022-02-21
5. Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way;Oxidative Medicine and Cellular Longevity;2022-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3